Reality of obesity paradox: Results of percutaneous coronary intervention in Middle Eastern patients

被引:2
|
作者
Jarrah, Mohamad [1 ]
Hammoudeh, Ayman J. [2 ]
Khader, Yousef [3 ]
Tabbalat, Ramzi [4 ]
Al-Mousa, Eyas [2 ]
Okkeh, Osama [5 ]
Alhaddad, Imad A. [6 ]
Tawalbeh, Loai Issa [7 ]
Hweidi, Issa M. [8 ]
机构
[1] King Abdullah Univ Hosp, Cardiol Sect, Dept Internal Med, Irbid, Jordan
[2] Istishari Hosp, Dept Cardiol, Amman, Jordan
[3] Jordan Univ Sci & Technol, Sch Allied Med Sci, Irbid, Jordan
[4] Khalidi Med Ctr, Dept Cardiol, Amman, Jordan
[5] Arab Med Ctr, Dept Cardiol, Amman, Jordan
[6] Jordan Hosp Med Ctr, Dept Cardiol, Amman, Jordan
[7] AL AlBayt Univ, Fac Nursing, Almafraq, Jordan
[8] Jordan Univ Sci & Technol, Fac Nursing, Irbid, Jordan
关键词
Cardiovascular disease; obesity; obesity paradox; Middle Eastern patients; percutaneous coronary intervention; major adverse cardiovascular events; BODY-MASS INDEX; ACUTE MYOCARDIAL-INFARCTION; ALL-CAUSE MORTALITY; LONG-TERM OUTCOMES; SCIENTIFIC STATEMENT; DIABETES-MELLITUS; ARTERY-DISEASE; WEIGHT-GAIN; RISK; ASSOCIATION;
D O I
10.1177/0300060518757354
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective The aim of this study was to assess the baseline clinical characteristics, coronary angiographic features, and adverse cardiovascular events during hospitalization and at 1 year of follow-up in obese patients compared with overweight and normal/underweight patients. Methods A prospective, multicenter study of consecutive patients undergoing percutaneous coronary intervention was performed. Results Of 2425 enrolled patients, 699 (28.8%) were obese, 1178 (48.6%) were overweight, and 548 (22.6%) were normal/underweight. Obese patients were more likely to be female and to have a higher prevalence of diabetes, hypertension, hypercholesterolemia, or previous percutaneous coronary intervention. Acute coronary syndrome was the indication for percutaneous coronary intervention in 77.0% of obese, 76.4% of overweight, and 77.4% of normal/underweight patients. No significant differences in the prevalence of multi-vessel coronary artery disease or multi-vessel percutaneous coronary intervention were found among the three groups. Additionally, no significant differences were found in stent thrombosis, readmission bleeding rates, or cardiac mortality among the three groups during hospitalization, at 1 month, and at 1 year. Conclusion The major adverse cardiovascular event rate was the same among the three groups throughout the study period. Accordingly, body mass index is considered a weak risk factor for cardiovascular comorbidities in Arab Jordanian patients.
引用
收藏
页码:1595 / 1605
页数:11
相关论文
共 50 条
  • [21] The "obesity-mortality paradox" phenomenon among Asian patients following percutaneous coronary artery intervention Reply
    Kaneko, Hidehiro
    JOURNAL OF CARDIOLOGY, 2013, 62 (5-6) : 380 - 380
  • [22] Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)
    Gurm, HS
    Brennan, DM
    Booth, J
    Tcheng, JE
    Lincoff, AM
    Topol, EJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (01): : 42 - +
  • [23] OBESITY PARADOX STILL EXISTS AFTER PERCUTANEOUS CORONARY INTERVENTION INDEPENDENT METABOLIC STATUS
    Han, Seung
    Oh, Pyung Chun
    Lee, Kyounghoon
    Suh, Soon Yong
    Kang, Woong Chol
    Koh, Kwang Kon
    Ahn, Tae Hoon
    Shin, Eak Kyun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1548 - A1548
  • [24] OBESITY PARADOX STILL EXISTS AFTER PERCUTANEOUS CORONARY INTERVENTION INDEPENDENT OF METABOLIC STATUS
    Han, S.
    Oh, P.
    Koh, K.
    Lee, K.
    Seo, S.
    Ahn, T.
    Shin, E.
    ATHEROSCLEROSIS, 2014, 235 (02) : E52 - E52
  • [25] Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1)
    Saleh, Akram
    Hammoudeh, Ayman
    Tabbalat, Ramzi
    Al-haddad, Imadd
    Al-Mousa, Eyass
    Jarrah, Mohammad
    Izraiq, Mahmoud
    Nammas, Assem
    Janabi, Husham
    Hazaymeh, Lewa
    Shakhatreh, Ali
    Khadder, Youssef
    ANNALS OF SAUDI MEDICINE, 2016, 36 (01) : 17 - 22
  • [26] Obesity, health status, and 7-year mortality in percutaneous coronary intervention: In search of an explanation for the obesity paradox
    Younge, John O.
    Damen, Nikki L.
    van Domburg, Ron T.
    Pedersen, Susanne S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (04) : 1154 - 1158
  • [27] Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction
    Kang, Won Yu
    Jeong, Myung Ho
    Ahn, Young Keun
    Kim, Jong Hyun
    Chae, Shung Chull
    Kim, Young Jo
    Hur, Seung Ho
    Seong, In Whan
    Hong, Taek Jong
    Choi, Dong Hoon
    Cho, Myeong Chan
    Kim, Chong Jin
    Seung, Ki Bae
    Chung, Wook Sung
    Jang, Yang Soo
    Rha, Seung Woon
    Bae, Jang Ho
    Cho, Jeong Gwan
    Park, Seung Jung
    JOURNAL OF CARDIOLOGY, 2010, 55 (01) : 84 - 91
  • [28] Kidney Function, Body Mass Index and Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention: Obesity Paradox Redux?
    Bimal, Tia
    Bhuiyan, Md
    Gandotra, Puneet
    Fishbein, Joanna
    Selim, Samy
    Ong, Lawrence
    Gruberg, Luis
    CIRCULATION, 2021, 144
  • [29] Untangling the obesity paradox in patients with acute myocardial infarction after primary percutaneous coronary intervention (detail analysis by age)
    Fukuoka, Shusuke
    Kurita, Tairo
    Dohi, Kaoru
    Masuda, Jun
    Seko, Tetsuya
    Tanigawa, Takashi
    Saito, Yasuhiro
    Kakimoto, Hitoshi
    Makino, Katsutoshi
    Ito, Masaaki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 289 : 12 - 18
  • [30] Percutaneous coronary intervention with drug eluting stents and impact of body mass index: The obesity paradox?
    Hassani, S-E.
    Wolfram, R.
    Raslova, N.
    Waksman, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 181 - 181